The association between cardiometabolic index (CMI) and metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global health challenge, with cardiovascular mortality. The cardiometabolic index (CMI), a biomarker derived by multiplying the waist-to-height ratio (WHtR) with the triglyceride-to-high-density lipoprotein cho...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Alireza Azarboo, Parisa Fallahtafti, Sayeh Jalali, Shaghayegh Khanmohammadi, Maysa Eslami, Farzad Pourghazi, Hannaneh Saadaeijahromi
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2025-08-01
Reeks:	Diabetology & Metabolic Syndrome
Onderwerpen:	Cardiometabolic index Metabolic dysfunction-associated steatotic liver disease Non-invasive biomarker
Online toegang:	https://doi.org/10.1186/s13098-025-01912-4
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!